Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Circio Holding ASA - Exercise of subscription rights in the rights issue by primary insiders

Oslo, 28 June 2024: Reference is made to the stock exchange announcements by Circio Holding ASA (the "Company") on 24 June 2024, regarding the commencement of the subscription period for the rights issue (the "Rights Issue") and the receipt of subscription rights in the Rights Issue by certain primary insiders and close associates. Robert Burns, a member of the board of directors, has on 27 June 2024 exercised 19,376 subscription rights, thus entitling him to be allocated 19,376 offer shares in the Rights Issue. In addition, Robert Burns has subscribed for 30,624 offer shares without

STOREBRAND ASA: Invitation to Result Presentation Q2 2024

In connection with the release of the results for Q2 2024, Storebrand invites to the following events:Friday 12 July 2024 07.30 CET Release of stock exchange notification. Press release, quarterly report and analyst presentation will be available on www.storebrand.com/ir . 10.00 CET Live streamed investor and analyst conference in English. A webcast will be available for everyone to view on www.storebrand.com/ir, and will be available on demand afterwards. Analysts who would like to ask

Inside Information: 23andMe and Nightingale Health Announce Strategic Collaboration to Pilot Blood Biomarker Panel

Nightingale Health PlcCompany release, inside information28 June 2024 at 2:00 p.m. (EEST) Nightingale Health Plc (“Nightingale Health”), a pioneer in disease risk detection and preventive health (HEL: HEALTH), and 23andMe Holding Co., a leading preventive health and therapeutics company, today announced a strategic collaboration to pilot Nightingale Health’s clinically-validated and cost-effective blood metabolomics panel with a cohort of 23andMe members. Nightingale’s Remote Health Check accurately measures dozens of biomarkers from a single blood sample, including cholesterols,

Bonava starts production of 66 housing units in Uppsala city centre

Bonava is starting production of 66 housing units in Uppsala city centre. The Seminariet project is located in Luthagen and is being built in two stages, with the first 66 homes expected to be handed over to customers in the second half of 2026. The neighbourhood will comprise a total of 113 apartments when completed.– There has been a great deal of interest from customers in Seminariet and we have reached a good booking ratio. We have worked with this project for many years and are delighted to provide Uppsala residents with new homes of the highest quality. In addition, Bonava is sprucing

FlexQube win its second AMR project in Sweden

FlexQube, in collaboration with a Swedish automation integrator, has secured a project with an international company in the aerospace industry. The project involves the installation of FlexQube's robotic product, Navigator AMR, an autonomous automation solution for material transportation and presentation. The project is scheduled for final delivery in the first quarter of 2025, with an order value of approximately SEK 1.55 million.  About FlexQube FlexQube is a technology company headquartered in Gothenburg, Sweden with subsidiaries in USA, Mexico, Germany and England. FlexQube

Fortaco completes the sale of its heavy project business in Hungary

Fortaco Group Holdco Plc  |  PRESS RELEASE  |  28 June 2024 at 2.00 pm EESTOn 10 May 2024, Fortaco announced that it had signed an agreement to sell its heavy project business (Fortaco Zrt.) in Jászberény, Hungary to Cyclus GmbH (50%) and Ask US Management s.r.o. (50%). The transaction is part of the strategic evaluation of Fortaco’s marine, energy, and heavy project businesses announced on 28 February 2024.   The transaction was subject to the approval of Fortaco’s bondholders and some customary closing conditions. As Fortaco’s bondholders have now approved the transaction and the

Vestas wins 81 MW order in the UK

News release from Vestas Northern and Central EuropeHamburg, 28 June 2024 Vestas has secured an 81 MW order from Invenergy for the wind energy project Pencloe in Dumfries and Galloway in Scotland, UK. Vestas will deliver 18 V136-4.5 MW wind turbines, and the order includes supply, delivery, installation, and commissioning of the turbines. Upon completion, Vestas will service the turbines under a multi-year Active Output Management 5000 (AOM 5000) service agreement designed to ensure optimised performance of the assets. “We are delighted to achieve this key milestone in our

Minutes from the 2024 Annual General Meeting of Risk Intelligence A/S

Risk Intelligence A/S ("Risk Intelligence" or "the Company") held its Annual General Meeting today on Friday 28 June 2024. Below are the minutes of the meeting.Today Friday 28 June 2024 at 10am, the Annual General Meeting 2024 in Risk Intelligence A/S was held at Skovshoved Hotel, Strandvejen 267, 2920 Charlottenlund.   The following was conducted, adopted and recorded according to the agenda sent out to the shareholders and posted on the Company’s website on 6 June 2024:   1.            Election of chairman of the meeting Attorney at law Sune Westrup was elected as chairman

Kyoto Group AS – Minutes from the annual general meeting held on 28 June 2024

Oslo, Norway 28 June 2024. Reference is made to the stock exchange announcement made by Kyoto Group AS ("Kyoto" or the "Company") on 14 June 2024 where the Company convened the annual general meeting. The annual general meeting was held today, and the Company is pleased to announce that the general meeting adopted all the proposed resolutions with the requisite majority, including the share capital increase in connection with the investment made by GF I Kiln HoldCo AS as part of the transaction announced on 14 June 2024.The minutes from the general meeting are attached to this announcement

Exel Composites' strategic initiatives in India and in Belgium are progressing accelerated by successful share issue

EXEL COMPOSITES PLC          INVESTOR NEWS       28 JUNE 2024 AT 13:30 EESTExel Composites Plc's strategic development projects have progressed in the first half of 2024 according to the announced plan.   Rights issue and new financing agreement strengthen balance sheet   Exel Composites Plc's rights issue, successfully completed in June, strengthens the company's financial position and enables accelerating the company’s growth and transformative strategy. In the clearly oversubscribed rights issue, with subscriptions received for approximately 141 per cent of the offer shares,

CS MEDICA A/S: Minutes of Extraordinary General Meeting

Today on June 28, 2024, in Copenhagen - CS MEDICA A/S (”CS MEDICA” or “The Company”) held an extraordinary general meeting at which the following principal resolutions were passed.Authorization for the company's board of directors to list CS MEDICA shares on the German Stock Exchange. The Extraordinary General Meeting (EGM) resolved in accordance with the Board of Directors’ proposal to authorize the company's board of directors to list the company on one of the multilateral trading facilities (MTF) in Germany. Authorization for the company's board of directors to list the company's

Cessatech presents new data on paediatric pain relief at the PAGE conference in Rome favouring its lead candidate CT001

· Optimal drug exposure for effective pain management, significant findings revealed that relative drug exposure is much higher in young children. · Enhanced understanding of paediatric nasal drug delivery underscores the importance of age-specific considerations in nasal drug delivery. · Efficacy of CT001 administration. solidifies the opioid-sparing advantage of the CT001 formulation, making it a safer option for paediatric patients.On 28 June – Cessatech A/S (“Cessatech” or “the Company”) announces that the presentation is now available from the Population Approach Group Europe (

Aker Solutions ASA: Invitation to presentation of second-quarter results for 2024

June 28, 2024 – Aker Solutions will publish its second-quarter results and half-year report for 2024 on Friday, July 12th, at 07:00 CEST. A live audiocast will take place on the same day at 09:30 CEST.Please note that the results will be presented by audiocast only. To join the live audiocast, go to https://www.akersolutions.com/audiocast A Q&A session will follow the presentation. Written questions can be submitted through the audiocast solution or sent in advance to preben.orbeck@akersolutions.com of investor relations.  An opportunity for individual press interviews will follow the

Wetteri Plc acquires Lahden Rekkapaja and executes a directed share issue

Wetteri Plc Stock Exchange Release 28 June 2024 at 13.00Automotive growth company Wetteri Oyj acquires Lahden Rekkapaja Oy and Kiinteistö Oy Lahden Konekatu 3 and executes its fifth acquisition in its series. Lahden Rekkapaja Oy is a company providing installation, maintenance, spare parts and repair services for heavy equipment bodybuildings. The company employs about 10 people. In the transaction, the buyer is Wetteri Plc, to whom the entire share capital of Kiinteistö Oy Lahden Konekatu 3 and Lahden Rekkapaja Oy will be transferred to. The purchase price is a total of EUR 1.4

Axentia signs framework agreement with Region Stockholm/AB Storstockholms Lokaltrafik (SL)

Axentia Technologies AB, part of Axentia Group AB (publ), has signed a framework agreement with Region Stockholm regarding continued cooperation for digital traffic information of real-time displays and text-to-speech with low-powered battery-operated technique. Upon entry into the framework agreement, the agreement is transferred from Region Stockholm Traffic Committee to AB Storstockholms Lokaltrafik (SL). The framework agreement is valid for 5 years with a possibility to extend the contract period with 3 years up to a total of 8 years. Axentia and SL have a long history of

NYAB receives order for power line construction worth SEK 122.1 million

NYAB has signed a contract for the construction of the new overhead lines from the new Degerträsk station to the steel mill and hydrogen plant in the Svartbyn operating area, also known as Boden Industrial Park. The purpose of the lines is to supply power to H2 Green Steel's operations.  The value of the project amounts to SEK 122.1 million.  "This project win is an important step in NYAB Sweden's expansion within energy. It clearly demonstrates the competence and expertise we possess in power line construction," says Mikael Ritola, COO at NYAB.  "Without all the committed and

Joe Biden’s odds balloon to record high following debate with Donald Trump

Not only did Joe Biden's Election odds plummeted following last night's Election debate with Donald Trump, but there was significant movement in the Democratic Candidate odds market, as people speculated on a potential replacement.Joe Biden’s odds to win the 2024 Election have been hovering around the 13/8 (+163) mark for a few weeks now, making him the narrow second favorite behind Donald Trump. Those odds would imply Joe Biden had a 38% chance of remaining in office.   However, following last night’s debate with rival Donald Trump, Joe Biden’s betting odds skyrocketed. Joe Biden is now

Change in the number of shares and votes in Projektengagemang Sweden AB (publ) following conversion

The number of shares and votes in Projektengagemang Sweden AB (publ) (Projektengagemang) has changed due to conversion of 57 600 class A shares to 57 600 class B shares.Pursuant to the articles of association of Projektengagemang, a holder of a class A share is entitled to request that the share is converted into a class B share. In June 2024, 57 600 class A shares have been converted into 57 600 class B shares, at the request of shareholders. After the conversion, as of June 28 2024, the total number of shares and votes in Projektengagemang amounted to 24 555 677 and 71 616 893,

SciBase partner with a large health care group in Los Angeles, Unified Health, and receives a first order

STOCKHOLM, SVERIGE, 28 June 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], SciBase], a leading developer of augmented intelligence-based solutions for skin disorders  announced today that it continues to expand in California with a collaboration agreement with Unified Health. Unified Health has nine clinics in Southern California.“At Unified Health, we believe in providing our patients with exceptional medical care and access to the most advance medical technology. Our experienced team of providers are committed to delivering the highest quality of dermatological care to our patients,

BioStock: Annexin comments on acquisition and focus on ANXV in ophthalmology

Merck recently announced that they are acquiring the biotech company EyeBio for up to 3 billion USD, thereby strengthening its presence in ophthalmology. EyeBio’s drug candidate Restoret is being developed to treat diabetes-related eye diseases. Another active player in the ophthalmology field is the Swedish company Annexin Pharmaceuticals. BioStock reached out to the company’s CEO Anders Haegerstrand to get his comments on the acquisition and gain further insights into Annexin’s focus for 2024.Read the full article at biostock.se : https://www.biostock.se/en/

Total Voting Rights

LEI: 254900Z4X5Y7NTODRI75 28 June 2024   Ashoka WhiteOak Emerging Markets Trust plc (the “Company”) Total voting Rights and Capital   In conformity with DTR 5.6.1R, the Company hereby announces that, as at 28 June 2024, the Company's issued share capital consisted of 32,831,795 Ordinary Shares. There are no ordinary shares held in Treasury. The total number of voting rights of the Company is 32,831,795 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in,

Conversion of shares in NCC AB, June 2024

According to NCC’s articles of association, owners of Series A shares are entitled to request that such shares be converted to Series B shares. Conversion reduces the total number of voting rights in the company.During June 2024, 300 Series A shares were converted to Series B shares at the request of shareholders, following which the total number of voting rights in the company amounts to 161,186,199. The total number of registered shares in the company amount to 99,760,956 of which 6,825,027 are Series A and 92,935,929 are Series B. NCC holds 1,968,589 Series B shares in treasury. In

Change in number of shares and votes in Episurf Medical

Episurf Medical AB (NASDAQ: EPIS B) has, pursuant to previously announced information, carried out a rights issue of units consisting of shares of series B and warrants of series TO13 B. The rights issue has resulted in a change in the number of shares and votes in the company. Through the rights issue, the number of shares has increased by 375,662,430 shares of series B and the number of votes has increased by 375,662,430. Furthermore, the company has, pursuant to previously announced information, carried out a set-off issue of units consisting of shares of series B and warrants of

Seres, Skywell and DFSK brand representations for Wetteri

Wetteri Oyj  Press release 28 June 2024 at 12.00Automotive growth company Wetteri becomes a representative of Chinese car brands Seres, Skywell and DFSK in Oulu and Kuopio. New brand representations strengthen Wetteri's passenger car brand representation in Finland and diversifies its selection of electric and hybrid vehicles. Aarne Simula, CEO and President, Wetteri Plc: “Wetteri's new brand representations respond to the demand for more affordable segments, but also offer great options in more expensive price ranges. There is interest in the market for more affordable electric and

There are no items matching the current filter
There are no more items matching the current filter
Back to top